Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines

Vaccine: X · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles